FDA Investigator Anthony R Rauert
Anthony R Rauert has conducted inspections on 222 sites in 1 countries as of 06 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
222
Last Inspection Date:
06 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Anthony R Rauert:
Affiong Flores,
Alan D Centi,
Alejandra Mcclellan,
Alice S Tsao,
Althea A Williams,
Amber D Brodas,
Amy Constantine,
Amy Kim,
Amy Wyan Mai,
Andrew F Cohen,
Andrew J Molesky,
Anna M Alexander,
Arduino Frankovic,
Armia A Beshay,
Arthur S Williams, Jr,
Ashley Defilippis,
Ashley Polizzotto,
Audrey Thereset Uy,
Ayorinde O Babalola,
Barbara J Maulfair,
Benjamin Bustamante,
Bernardica T Sculac Stern,
Brandon J Brookens,
Brian M Brodman,
Brian S Keefer,
Camille D Monde,
Cara M Minelli,
Carlos A Guzman,
Carrie E Jolly,
Cassandra Gasby,
Charisse K Green,
Christian Parra,
Christine M Rivera,
Christopher S Fields,
Cosmon L Barrett,
Crystal A Harlan,
Daniel Green,
David A Trent Carlson,
David I Cho,
David M Mcnew,
David R Delucia,
Dhaval H Patel,
Diane B Radice,
Dipesh K Shah,
Donald J Ullstrom,
Douglas G Ng,
Duo D Chen,
Edwin A Evangelista,
Elsie E Figueroa Ortiz,
Emilio Z Azukwu,
Emily J Schramm,
Eric Rothschild,
Eric S Myskowski,
Erica B Raphael,
Feryal Ahmad,
Frank A Boardwick,
Frank J Koch,
Gabriel Feng,
Gayle J Gehrman,
Huascar Batista,
Jackson Y See,
Jana J Lau,
Jananiga Vanniyasingam,
Janaysia N Trail,
Jane C Chen,
Jason John A Ng,
Jason Kwong,
Jeannie R Mayberry,
Jeffrey A Reed,
Jennifer L Custodio,
Jerri E Lothrop,
Jesse N Nardone,
Jesse Ray N Nardone,
Joannette Roman,
John E Aghadia,
John P Sakowski,
Johnmartin Jackson,
Jose Ohernandez Guzman,
Joseph Duca,
Joseph Maselli,
Joseph Milcetic,
Joseph O Sullivan,
Joseph S Tomao,
Joseph T Dougherty,
Joshua C Schafer,
Joshua L Gibbs,
Joy P Matthias,
Judith A Paterson,
Judy Keihl,
Juliana Falla,
Katrina M D'egidio,
Kevin A Gonzalez,
Kim G Campbell,
Kimberley A Ricketts,
Kimberly A Coward,
Kristen C Jackson,
Kwong P Lee,
Kyle D Covill,
Laishan L Lam,
Lawrence R Johnson,
Leticia S Jones,
Lydia E Gonzalez,
Mary M Finn,
Melba Trivera Clavell,
Melissa M Dauksis,
Melissa M Schafer,
Melissa N Gregorio,
Melka F Argaw,
Meredith P Soehl, Investigator,
Michael R Dominick,
Michele C Murray Schrade,
Milan S Kunajukr,
Milan S Mcgorty,
Morgan J Matthews,
Mouhamed H Halwani,
Nasser Yazdani, DVM, MPH,
Nawab A Siddiqui,
Nazmul Hassan,
Nicholas J Morici,
Nichole B Murphy,
Nicole Vaught,
Nur M Faisal,
Omolola A Shola Philips,
Onieka T Carpenter,
Osama A Khatib,
Pasquale L Leone,
Patricia A Ellis,
Patrick A Bowen,
Paul M Gelfand,
Pearl L Gonzalez,
Perez,
Peter M Trunk,
Peter R Caparelli,
Peter R Lenahan,
Rachel E Wapniak,
Randolph Campos Santiago,
Raymond Liu,
Raymond M Lam,
Regina Moore,
Richard J Anderson,
Rita F Monfort,
Robert C Howard,
Robert E Moncayo,
Ronald Ifraimov,
Ryan J Aguillon,
Samantha N Mccormick,
Samina S Khan,
Samuel A Francis,
Sarah A Meehan,
Sarah K Graham,
Satheesh Thomas,
Seemay A Lee,
Selina M Mata,
Shamel Jaime,
Shannon A Dinardo,
Shantel S Brown,
Sherri J Liu,
Shreya Shah,
Sinai I Davis,
Stanley Noneze,
Stephanie M Roberts Pedotti,
Sunita Vij,
Susan M Halsted,
Suwaskie S Smith,
Taina Pierre Pierre,
Tamara M Simpson,
Tara K Carmody,
Tara K Normandin,
Terry E Pierre,
Todd J Maushart,
Tracy M Portelli,
Vaishali J Patel,
Valerie A Potopsingh,
Valerie C Reed,
Vanessa M Williams,
Vincent T Duncan,
Virginia A Chung,
Wai H Lam,
Wayne J Meyer,
Wendy A Johnecheck,
William C Brenneman,
William V Thompson,
Willy A Orantes,
Winston A Oliver,
Yasmin B Rios,
Yuyan Liang,
Zameer Farouk
Anthony R Rauert's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2021 | FDA 483 | NUPUR TRADING LLC - Form 483, 2021-01-28 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more